- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05517629
Face Mask Habits and COVID-19 Among University Students in Cairo
Face Mask Habits and COVID-19: A Cross-Sectional Study of University Students During the Third Wave in Greater Cairo
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study design and participants:
This cross-sectional study is going to be carried out at a time when wearing masks in public places, transportation and universities is mandatory. The questionnaire which is designed to collect the data is targeted to college students who are attending universities in Greater Cairo, Egypt. The questionnaire will be left open for a duration of 10 days to collect the required responses.
Data collection:
The data is going to be collected from a questionnaire that we created using Google forms, consisting of 33 questions. It was written in English then translated to Arabic to be understandable to as many people as possible. The survey will be sent using a snowball sampling method to the participants through various social media applications such as: Facebook, Twitter, WhatsApp, Snapchat, and Telegram. A pilot study of the questionnaire will be pre-tested on a small sample of participants to confirm the practicability and clarity of questions to check content and face validity. In addition, the reliability will be determined by calculating Cronbach alpha. Observations of the pilot study will not be included in the final analysis.
Statistical analysis:
Dichotomous data will be expressed by numbers and frequency. Continuous variables will be expressed by means and standard deviation if within the normal distribution. Range and interquartile range will be used to express continuous data within the non-normal distribution. Data will be exported to an excel sheet from Google forms and will be analyzed by an expert using IBM SPSS Statistics program.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Banhā, Egypt
- Benha University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- The target population was limited to individuals aged 18 to 28 years, as those individuals can provide consent and represent the undergraduate and graduate sections.
- The participants were asked about the location of their campuses to ensure that their responses were limited only to the universities in Greater Cairo.
Exclusion Criteria:
- Individuals below the age of 18 years old are not old enough to provide consent, and individuals above the age of 28 are considered postgraduate.
- To make sure that responses arrived only from Greater Cairo universities, a question asking about the location of university campus is added to exclude responses from outside the specified area which only includes the cities of Cairo, Giza, Helwan (15th of May), Shubra El Kheima, 6th of October, Sheikh Zayed City, Badr, New Cairo (including Rehab and Fifth Settlement), New Heliopolis, Obour, Shorouk, Madinaty21.
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
All the time
Students who wore face masks all the time when outside
|
It is an observational cross-sectional study
|
|
Most of the time
Students who wore face masks most of the time when outside
|
It is an observational cross-sectional study
|
|
Only when told to
Students who wore face masks only when they were told to when outside
|
It is an observational cross-sectional study
|
|
Not At All
Students who did not wear face masks at all when outside
|
It is an observational cross-sectional study
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Face Mask Habits
Time Frame: April 20, 2021
|
To evaluate participants' attitudes regarding face masks, the questions were grouped into two aspects: face mask habits (14 items) and COVID-19.
Scoring Grade are four grades 1.
Using face mask at all, 2. Using face mask most of time, 3. Using face mask when you are told to, and 4.
Not using face mask.
|
April 20, 2021
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Manar A Kamal, MBBCh, Benha University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FMASU R 59/2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COVID-19
-
PfizerActive, not recruitingCOVID-19 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | COVID-19 Vaccines | SARS-CoV-2 Infection, COVID19 | COVID-19 Vaccination | SARS-CoV-2 Infection, COVID-19 | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionUnited States
-
Shanghai Public Health Clinical CenterNot yet recruiting
-
Duke UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Eggensberger OHGBavarian Health and Food Safety Authority (LGL)RecruitingPost COVID-19 Condition | Post COVID-19 | Post COVID-19 Syndrome | Long COVID-19 Syndrome | Post COVID-19 Condition (PCC)Germany
-
PfizerRecruitingRespiratory Tract Diseases | COVID-19 | Pneumonia | Lung Diseases | Coronavirus Disease 2019 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | Upper Respiratory Tract Infections | Respiratory Tract Infection | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionBelgium
-
ModeX Therapeutics, An OPKO Health CompanyRecruitingCOVID -19 | COVID-19 (Prevention)United States
-
Lawson Research Institute of St. Joseph'sCanadian Institutes of Health Research (CIHR); Western University, CanadaRecruitingFatigue | Post-COVID-19 Syndrome | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19 | Long-COVID | Post-COVID ConditionCanada
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios Prevention SrlCompletedPost Acute Sequelae of COVID-19 | Post COVID-19 Condition | Long-COVID | Chronic COVID-19 SyndromeItaly
-
Yang I. PachankisActive, not recruitingCOVID-19 Respiratory Infection | COVID-19 Stress Syndrome | COVID-19 Vaccine Adverse Reaction | COVID-19-Associated Thromboembolism | COVID-19 Post-Intensive Care Syndrome | COVID-19-Associated StrokeChina
-
University of Missouri, Kansas CityNational Institute on Minority Health and Health Disparities (NIMHD)Active, not recruitingCOVID-19 Testing BehaviorsUnited States
Clinical Trials on It is an observational cross-sectional study
-
Texas Tech UniversityCompletedGender | Early Adolescent BehaviorUnited States
-
Alexandria UniversityCompletedMyalgic EncephalomyelitisEgypt
-
Scandinavia PharmaRecruitingGastroesophageal Reflux DiseaseColombia
-
Children's Hospital of Fudan UniversityCompletedProlonged Mechanical VentilationChina
-
Royal Brompton & Harefield NHS Foundation TrustUnknownEvaluation of Speckle Tracking Parameters as Predictors of Successful VA SPECKLE ECMO (SPECKLE-ECMO)Cardiogenic ShockUnited Kingdom
-
Danone Asia Pacific Holdings Pte, Ltd.Completed
-
Istituti Clinici Scientifici Maugeri SpACompletedDepression | Cardiovascular Diseases | Anxiety | Rehabilitation | Psychological Distress | Pulmonary Disease | Coping BehaviorItaly
-
Oxford University Hospitals NHS TrustCompleted
-
CalydialCompletedHemodialysis | DIALYSIS SYMPTOMS AND ANXIETYFrance